-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

504.P1.18 504. Hematopoiesis: Cytokines, Signal Transduction, Apoptosis and Cell Cycle Regulation: Poster I

Hematopoiesis: Cytokines, Signal Transduction, Apoptosis and Cell Cycle Regulation Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 5, 2015: 5:30 PM-7:30 PM
Hall A, Level 2 (Orange County Convention Center)

Pan Li1,2*, Rose McGlauflin1*, Amanda J Favreau1, Edward Jachimowicz3*, Calvin Vary1*, Kailin Xu2*, Don M Wojchowski4 and Pradeep Sathyanarayana5

1Maine Medical Center Research Institute, Scarborough, ME
2Department of Hematology, The Affiliated Hospital of Xuzhou Medical College, Xuzhou, China
3COBRE Center of Excellence in Stem & Progenitor Cell Biology and Regenerative Medicine, Maine Medical Center Research Institute, Scarborough, ME
4COBRE Center of Excellence in Stem Cell Biology and Regenerative Medicine, Maine Medical Center Research Institute, Scarborough, ME
5Center for Molecular Medicine, Maine Medical Center Research Institute, Scarborough, ME

Yajie Wang1*, Sha Hao, Ph.D.1*, Ping Lu, M.Sc.1*, Hui Cheng, Ph.D.1,2*, Yuemin Gong1* and Tao Cheng, MD1,2,3

1Institute of Hematology & Blood Diseases Hospital, State Key Laboratory of Experimental Hematology, Tianjin, China
2Center for Stem Cell Medicine, Tianjin, China
3Department of Stem Cell and Regenerative Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Azadeh Zahabi1*, Tatsuya Morishima, MD, PhD1*, Andri Pramono2*, Dan Lan2*, Lothar Kanz, MD3, Karl Welte, MD4* and Julia Skokowa, Prof. Dr.1*

1Division of Translational Oncology, Department of Oncology, Hematology, Immunology, Rheumatology and Pulmonology, University Hospital Tuebingen, Tuebingen, Germany
2Division of Translational Oncology, Department of Hematology, Oncology, Immunology, Rheumatology and Pulmonology, University Hospital Tuebingen, Tuebingen, Germany
3Dept. of Hematology, Oncology, Rheumatology, Immunology and Pulmology, University Hospital Tübingen, Tübingen, Germany
4University Children’s Hospital Tuebingen, Tuebingen, Germany

Deven V. Parmar, MD, Daniel Byczkowski*, Ronald G. Jubin, PhD, Abraham Abuchowski, PhD*, Peter Buontempo, MSc, BSc*, Gerry Gitlin*, Michelle Boro* and Hemant K. Misra, PhD

Prolong Pharmaceuticals, South Plainfield, NJ

Susanne Wingert, MSc1*, Frederic B Thalheimer, PhD1*, Nadine Haetscher, MSc1*, Maike Rehage, PhD1*, Hubert Serve, MD2, Timm Schroeder, PhD3* and Michael A. Rieger, PhD1*

1LOEWE Center for Cell and Gene Therapy and Department for Hematology/Oncology, Goethe-University Hospital Frankfurt, Frankfurt am Main, Germany
2Department for Hematology/Oncology, Goethe-University Hospital Frankfurt, Frankfurt am Main, Germany
3Department of Biosystems Science and Engineering (D-BSSE), Swiss Federal Institute of Technology (ETH) Zürich, Basel, Switzerland

Sakiko Suzuki, MD*, Nathan A Manalo, B.A. M.A.* and Glen D Raffel, M.D, Ph.D.

Division of Hematology/Oncology, University of Massachusetts Medical School, Worcester, MA

*signifies non-member of ASH